Publicaciones (41) Publicaciones de IRYNA RUSANOVA RUSANOVA

2024

  1. Inflamma-miRs Profile in Myelodysplastic Syndrome Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 12

  2. Machine Learning Model to Classify Patients with Complicated and Uncomplicated Type 2 Diabetes Mellitus in the New Civil Hospital of Guadalajara “Juan I. Menchaca”

    IFMBE Proceedings

  3. Unveiling the Predictive Model for Macrovascular Complications in Type 2 Diabetes Mellitus: microRNAs Expression, Lipid Profile, and Oxidative Stress Markers

    International Journal of Molecular Sciences, Vol. 25, Núm. 21

2023

  1. Chronodisruption and Loss of Melatonin Rhythm, Associated with Alterations in Daily Motor Activity and Mitochondrial Dynamics in Parkinsonian Zebrafish, Are Corrected by Melatonin Treatment

    Antioxidants, Vol. 12, Núm. 4

  2. Insights into the Role of Plasmatic and Exosomal microRNAs in Oxidative Stress-Related Metabolic Diseases

    Antioxidants, Vol. 12, Núm. 6

  3. Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress

    Biomedicine and Pharmacotherapy, Vol. 167

2022

  1. Age and Chronodisruption in Mouse Heart: Effect of the NLRP3 Inflammasome and Melatonin Therapy

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  2. Role of c-miR-21, c-miR-126, Redox Status, and Inflammatory Conditions as Potential Predictors of Vascular Damage in T2DM Patients

    Antioxidants, Vol. 11, Núm. 9

  3. Understanding the Mechanism of Action of Melatonin, Which Induces ROS Production in Cancer Cells

    Antioxidants, Vol. 11, Núm. 8

2021

  1. Article the impact of melatonin and nlrp3 inflammasome on the expression of micrornas in aged muscle

    Antioxidants, Vol. 10, Núm. 4

  2. Melatonin alleviates sepsis-induced heart injury through activating the Nrf2 pathway and inhibiting the NLRP3 inflammasome

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 394, Núm. 2, pp. 261-277

  3. Melatonin targets metabolism in head and neck cancer cells by regulating mitochondrial structure and function

    Antioxidants, Vol. 10, Núm. 4

  4. The impact of melatonin supplementation and nlrp3 inflammasome deletion on age-accompanied cardiac damage

    Antioxidants, Vol. 10, Núm. 8

2020

  1. Daily changes in the expression of clock genes in sepsis and their relation with sepsis outcome and urinary excretion of 6-sulfatoximelatonin

    Shock

2019

  1. Involvement of plasma miRNAs, muscle miRNAs and mitochondrial miRNAs in the pathophysiology of frailty

    Experimental Gerontology, Vol. 124

  2. Protective effects of melatonin on the skin: Future perspectives

    International Journal of Molecular Sciences, Vol. 20, Núm. 19

2018

  1. Analysis of Plasma MicroRNAs as Predictors and Biomarkers of Aging and Frailty in Humans

    Oxidative Medicine and Cellular Longevity, Vol. 2018

  2. Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation

    Journal of Pineal Research, Vol. 64, Núm. 3

  3. In Vivo Determination of Mitochondrial Respiration in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Zebrafish Reveals the Efficacy of Melatonin in Restoring Mitochondrial Normalcy

    Zebrafish, Vol. 15, Núm. 1, pp. 15-26

  4. The Protective Effect of Melatonin Against Age-Associated, Sarcopenia-Dependent Tubular Aggregate Formation, Lactate Depletion, and Mitochondrial Changes

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 73, Núm. 10, pp. 1330-1338